Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Ohr Pharmceutial (OHRP)

0.205 0 (0%)

05-25 16:00

Open:

0.2

Pre. Close:

0.205

High:

0.2087

Low:

0.1925

Volume:

258,362

Market Cap:

12M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.21 - 0.212

0.212 - 0.212

Low:

0.187 - 0.189

0.189 - 0.19

Close:

0.198 - 0.2

0.2 - 0.202

Technical analysis  (as of: 2018-05-25 4:37:48 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.25     One year: 0.28

Support:

Support1: 0.18    Support2: 0.15

Resistance:

Resistance1: 0.22    Resistance2: 0.24

Pivot:

0.20

Moving Averages:

MA(5): 0.20     MA(20): 0.21

MA(100): 0.29     MA(250): 0.60

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 43.33     %D(3): 32.22

RSI:

RSI(14): 45.60

52-Week:

High: 2.18  Low: 0.18  Change(%): -66.9

Average Vol(K):

3-Month: 47810  10-Days 25447

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
OHRP has closed below upper band by 48.5%. Bollinger Bands are 89.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to OHRP's normal range. The bands have been in this narrow range for 83 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-15T16:28:37-04:00
Ohr Pharmaceutical beats by $0.03

2018-04-05T18:00:00-04:00
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018

2018-04-05T15:50:00-04:00
OHR LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Ohr Pharmaceutical, Inc. To Contact The Firm

2018-03-26T17:17:00-04:00
OHRP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018

2018-03-20T15:55:00-04:00
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018

2018-03-20T15:09:00-04:00
Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc.

2018-03-19T16:04:00-04:00
The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 (OHRP)

2018-03-16T15:50:00-04:00
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ohr Pharmaceutical, Inc. to Contact the Firm

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

56.47

Shares Float (M)

54.81

% Held by Insiders

2.90

% Held by Institutions

15.10

Shares Short (K)

1841

Shares Short Prior Month (K)

671

Stock Financials

EPS

-0.430

EPS Est. Current Year

-0.950

EPS Est. Next Year

-1.550

EPS Est. Next Quarter

Forward EPS

-0.801

Book Value (p.s.)

0.610

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-79.0

Return on Equity (ttm)

-92.2

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.220

Qtrly Earnings Growth

Operating Cash Flow (M)

-17.56

Levered Free Cash Flow (M)

-10.17

atoplab.com

Valuation

P/E

-0.48

P/E Growth Ratio

-0.02

P/BV

0.34

P/S

P/CF

-0.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2013-06-03

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.